Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- Legend
- PPalliative care items
- MPMedical Practitioner
- MWMidwife
- NPNurse Practitioner
-
SO
Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MPNP | 13523R | DABIGATRANdabigatran etexilate 110 mg capsule, 60 | 2 | 120 | 5 |
MPNP | 2753X | DABIGATRANdabigatran etexilate 110 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 9321N | DABIGATRANdabigatran etexilate 110 mg capsule, 60 | 1 | 60 | 0 |
MPNP | 9320M | DABIGATRANdabigatran etexilate 75 mg capsule, 60 | 1 | 60 | 0 |
MPNP | 13489Y | DABIGATRANdabigatran etexilate 150 mg capsule, 60 | 2 | 120 | 5 |
MPNP | 2769R | DABIGATRANdabigatran etexilate 150 mg capsule, 60 | 1 | 60 | 5 |
MPNP | 9318K | DABIGATRANdabigatran etexilate 75 mg capsule, 10 | 2 | 20 | 1 |
MPNP | 9322P | DABIGATRANdabigatran etexilate 75 mg capsule, 10 | 2 | 20 | 0 |
MPNP | 9319L | DABIGATRANdabigatran etexilate 110 mg capsule, 10 | 2 | 20 | 1 |
MPNP | 9323Q | DABIGATRANdabigatran etexilate 110 mg capsule, 10 | 2 | 20 | 0 |
MPNP | 1779P | DANTROLENEdantrolene sodium hemiheptahydrate 25 mg capsule, 100 | 1 | 100 | 2 |
MPNP | 10011X | DAPAGLIFLOZINdapagliflozin 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 12823X | DAPAGLIFLOZINdapagliflozin 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13106T | DAPAGLIFLOZINdapagliflozin 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13844P | DAPAGLIFLOZINdapagliflozin 10 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 14054Q | DAPAGLIFLOZINdapagliflozin 10 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 14073Q | DAPAGLIFLOZINdapagliflozin 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 10510E | DAPAGLIFLOZIN + METFORMINdapagliflozin 5 mg + metformin hydrochloride 1 g modified release tablet, 56 | 1 | 56 | 5 |
MPNP | 13851B | DAPAGLIFLOZIN + METFORMINdapagliflozin 5 mg + metformin hydrochloride 1 g modified release tablet, 56 | 2 | 112 | 5 |
MPNP | 10515K | DAPAGLIFLOZIN + METFORMINdapagliflozin 10 mg + metformin hydrochloride 1 g modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 13875G | DAPAGLIFLOZIN + METFORMINdapagliflozin 10 mg + metformin hydrochloride 1 g modified release tablet, 28 | 2 | 56 | 5 |
MPNP | 10516L | DAPAGLIFLOZIN + METFORMINdapagliflozin 10 mg + metformin hydrochloride 500 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 14028H | DAPAGLIFLOZIN + METFORMINdapagliflozin 10 mg + metformin hydrochloride 500 mg modified release tablet, 28 | 2 | 56 | 5 |
MPNP | 1272Y | DAPSONEdapsone 100 mg tablet, 100 | 1 | 100 | 1 |
MPNP | 8801F | DAPSONEdapsone 25 mg tablet, 100 | 1 | 100 | 1 |
MPNP | 10329P | DARUNAVIRdarunavir 600 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 12946J | DARUNAVIRdarunavir 600 mg tablet, 2 x 30 | 2 | 120 | 5 |
MPNP | 10367P | DARUNAVIRdarunavir 800 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 12111K | DARUNAVIRdarunavir 800 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 10903W | DARUNAVIR + COBICISTATdarunavir 800 mg + cobicistat 150 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11955F | DARUNAVIR + COBICISTAT + EMTRICITABINE + TENOFOVIR ALAFENAMIDEdarunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 10061M | DENOSUMABdenosumab 120 mg/1.7 mL injection, 1.7 mL vial | 1 | 1 | 5 |
MPNP | 5110Y | DENOSUMABdenosumab 120 mg/1.7 mL injection, 1.7 mL vial | 1 | 1 | 5 |
MPNP | 5457F | DENOSUMABdenosumab 60 mg/mL injection, 1 mL syringe | 1 | 1 | 0 |
MPNP | 12459R | DESMOPRESSINdesmopressin acetate 10 microgram/actuation nasal spray, 50 actuations | 1 | 1 | 5 |
MPNP | 8712M | DESMOPRESSINdesmopressin acetate 10 microgram/actuation nasal spray, 60 actuations | 1 | 1 | 5 |
MPNP | 13945Y | DESMOPRESSINdesmopressin acetate 200 microgram tablet, 30 | 2 | 60 | 5 |
MPNP | 8663Y | DESMOPRESSINdesmopressin acetate 200 microgram tablet, 30 | 1 | 30 | 5 |
MPNP | 14004C | DESMOPRESSINdesmopressin 120 microgram sublingual wafer, 30 | 2 | 60 | 5 |
MPNP | 9398P | DESMOPRESSINdesmopressin 120 microgram sublingual wafer, 30 | 1 | 30 | 5 |
MPNP | 13890C | DESMOPRESSINdesmopressin 240 microgram sublingual wafer, 30 | 2 | 60 | 5 |
MPNP | 8975J | DESMOPRESSINdesmopressin 240 microgram sublingual wafer, 30 | 1 | 30 | 5 |
MPNP | 10231L | DESVENLAFAXINEdesvenlafaxine 100 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 10245F | DESVENLAFAXINEdesvenlafaxine 100 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 9367B | DESVENLAFAXINEdesvenlafaxine 100 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 10234P | DESVENLAFAXINEdesvenlafaxine 50 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 10241B | DESVENLAFAXINEdesvenlafaxine 50 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 9366Y | DESVENLAFAXINEdesvenlafaxine 50 mg modified release tablet, 28 | 1 | 28 | 5 |
MPNP | 1288T | DEXAMETHASONEdexamethasone 0.1% eye drops, 5 mL | 1 | 1 | 2 |
MPNP | 2507Y | DEXAMETHASONEdexamethasone 4 mg tablet, 30 | 1 | 30 | 4 |
MPNP | 1292B | DEXAMETHASONEdexamethasone 500 microgram tablet, 30 | 1 | 30 | 4 |
MPNP | 14007F | DEXAMETHASONEdexamethasone 500 microgram tablet, 30 | 2 | 60 | 4 |
MPNP | 1165H | DEXAMFETAMINEdexamfetamine sulfate 5 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 8299T | DEXTRAN-70 + HYPROMELLOSEdextran-70 0.1% + hypromellose 0.3% eye drops, 28 x 0.4 mL ampoules | 3 | 3 | 5 |
MPNP | 1509K | DEXTRAN-70 + HYPROMELLOSEdextran-70 0.1% + hypromellose 0.3% eye drops, 15 mL | 1 | 1 | 5 |
MPNP | 2669L | DIAZEPAMdiazepam 10 mg/10 mL oral liquid, 100 mL | 1 | 1 | 0 |
MPNP | 3161J | DIAZEPAMdiazepam 2 mg tablet, 50 | 1 | 50 | 0 |
MPNP | 5355W | DIAZEPAMdiazepam 2 mg tablet, 50 | 1 | 50 | 3 |
MPNP | 3162K | DIAZEPAMdiazepam 5 mg tablet, 50 | 1 | 50 | 0 |
MPNP | 5356X | DIAZEPAMdiazepam 5 mg tablet, 50 | 1 | 50 | 3 |
MPNP | 1300K | DICLOFENACdiclofenac sodium 50 mg enteric tablet, 50 | 1 | 50 | 3 |
MPMWNP | 1302M | DICLOFENACdiclofenac sodium 100 mg suppository, 20 | 2 | 40 | 3 |
MPNP | 1299J | DICLOFENACdiclofenac sodium 25 mg enteric tablet, 50 | 2 | 100 | 3 |
MPMWNP | 8121K | DICLOXACILLINdicloxacillin 250 mg capsule, 24 | 1 | 24 | 0 |
MPMWNP | 8122L | DICLOXACILLINdicloxacillin 500 mg capsule, 24 | 1 | 24 | 0 |
MPNP | 3164M | DIGOXINdigoxin 50 microgram/mL oral liquid, 60 mL | 2 | 2 | 3 |
MPNP | 1322N | DIGOXINdigoxin 250 microgram tablet, 100 | 1 | 100 | 1 |
MPNP | 2605D | DIGOXINdigoxin 62.5 microgram tablet, 200 | 1 | 200 | 1 |
MPNP | 1312C | DILTIAZEMdiltiazem hydrochloride 180 mg modified release capsule, 30 | 1 | 30 | 5 |
MPNP | 1313D | DILTIAZEMdiltiazem hydrochloride 240 mg modified release capsule, 30 | 1 | 30 | 5 |
MPNP | 8480H | DILTIAZEMdiltiazem hydrochloride 360 mg modified release capsule, 30 | 1 | 30 | 5 |
MPNP | 1335G | DILTIAZEMdiltiazem hydrochloride 60 mg tablet, 90 | 1 | 90 | 5 |
MPNP | 2501P | DIPHENOXYLATE + ATROPINE SULFATEdiphenoxylate hydrochloride 2.5 mg + atropine sulfate monohydrate 25 microgram tablet, 20 | 1 | 20 | 0 |
MPNP | 3463G | DIPHTHERIA + TETANUS VACCINEdiphtheria 2 units + tetanus 20 units vaccine injection, 5 x 0.5 mL syringes | 2 | 10 | 0 |
MPNP | 8783G | DIPHTHERIA + TETANUS VACCINEdiphtheria 2 units + tetanus 20 units vaccine injection, 5 x 0.5 mL syringes | 1 | 5 | 0 |
MPNP | 2923W | DISOPYRAMIDEdisopyramide 100 mg capsule, 100 | 1 | 100 | 5 |
MPNP | 13280Y | DISOPYRAMIDEdisopyramide 100 mg capsule, 84 | 1.19 | 100 | 5 |
MPNP | 10283F | DOLUTEGRAVIRdolutegravir 50 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 10345L | DOLUTEGRAVIR + ABACAVIR + LAMIVUDINEdolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11843H | DOLUTEGRAVIR + LAMIVUDINEdolutegravir 50 mg + lamivudine 300 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 11540J | DOLUTEGRAVIR + RILPIVIRINEdolutegravir 50 mg + rilpivirine 25 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 1347X | DOMPERIDONEdomperidone 10 mg tablet, 25 | 1 | 25 | 0 |
MPNP | 2479L | DONEPEZILdonepezil hydrochloride 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 2532G | DONEPEZILdonepezil hydrochloride 5 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 1357K | DOSULEPIN (DOTHIEPIN)dosulepin (dothiepin) hydrochloride 25 mg capsule, 50 | 1 | 50 | 2 |
MPNP | 1358L | DOSULEPIN (DOTHIEPIN)dosulepin (dothiepin) hydrochloride 75 mg tablet, 30 | 1 | 30 | 2 |
MPNP | 5705G | DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL)doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial | 4 | 4 | 5 |
MPNP | 6249X | DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL)doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial | 4 | 4 | 5 |
MPNP | 2708M | DOXYCYCLINEdoxycycline 100 mg modified release capsule, 7 | 1 | 7 | 1 |
MPNP | 2703G | DOXYCYCLINEdoxycycline 100 mg modified release capsule, 7 | 4 | 28 | 0 |
MPNP | 2715X | DOXYCYCLINEdoxycycline 100 mg modified release capsule, 21 | 1 | 21 | 0 |
MPNP | 2707L | DOXYCYCLINEdoxycycline 50 mg modified release capsule, 25 | 1 | 25 | 5 |
MPNP | 2702F | DOXYCYCLINEdoxycycline 100 mg tablet, 7 | 4 | 28 | 0 |
MPNP | 2709N | DOXYCYCLINEdoxycycline 100 mg tablet, 7 | 1 | 7 | 1 |
MPNP | 2714W | DOXYCYCLINEdoxycycline 100 mg tablet, 7 | 3 | 21 | 0 |
MPNP | 9105F | DOXYCYCLINEdoxycycline 100 mg tablet, 7 | 1 | 7 | 1 |
MPNP | 9107H | DOXYCYCLINEdoxycycline 100 mg tablet, 7 | 4 | 28 | 0 |
MPNP | 9108J | DOXYCYCLINEdoxycycline 100 mg tablet, 7 | 3 | 21 | 0 |
MPNP | 2711Q | DOXYCYCLINEdoxycycline 50 mg tablet, 25 | 1 | 25 | 5 |
MPNP | 9106G | DOXYCYCLINEdoxycycline 50 mg tablet, 25 | 1 | 25 | 5 |
MPNP | 10176N | DOXYCYCLINEdoxycycline 100 mg tablet, 21 | 1 | 21 | 0 |
MPNP | 11364D | DULAGLUTIDEdulaglutide 1.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices | 1 | 4 | 5 |
MPNP | 9155W | DULOXETINEduloxetine 30 mg enteric capsule, 28 | 1 | 28 | 0 |
MPNP | 9156X | DULOXETINEduloxetine 60 mg enteric capsule, 28 | 1 | 28 | 5 |
MPNP | 13900N | DUTASTERIDEdutasteride 500 microgram capsule, 30 | 2 | 60 | 5 |
MPNP | 5468T | DUTASTERIDEdutasteride 500 microgram capsule, 30 | 1 | 30 | 5 |
MPNP | 13929D | DUTASTERIDE + TAMSULOSINdutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30 | 2 | 60 | 5 |
MPNP | 5490Y | DUTASTERIDE + TAMSULOSINdutasteride 500 microgram + tamsulosin hydrochloride 400 microgram modified release capsule, 30 | 1 | 30 | 5 |